-
Je něco špatně v tomto záznamu ?
Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire
JM. Halimi, P. Sarafidis, M. Azizi, G. Bilo, T. Burkard, M. Bursztyn, M. Camafort, N. Chapman, S. Cottone, T. de Backer, J. Deinum, P. Delmotte, M. Dorobantu, M. Doumas, R. Dusing, B. Duly-Bouhanick, JP. Fauvel, P. Fesler, Z. Gaciong, E....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- antihypertenziva terapeutické užití MeSH
- chronická renální insuficience * komplikace patofyziologie MeSH
- hodnoty glomerulární filtrace MeSH
- hypertenze * farmakoterapie komplikace MeSH
- konziliární vyšetření a konzultace MeSH
- lidé středního věku MeSH
- lidé MeSH
- pilotní projekty MeSH
- plošný screening metody MeSH
- průzkumy a dotazníky MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
OBJECTIVE: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. METHODS: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (ESH-ECs) at first referral visit. The questionnaire contained 64 questions with which ESH-ECs representatives were asked to estimate preexisting CKD management quality. RESULTS: Overall, 88 ESH-ECs from 27 countries participated (fully completed surveys: 66/88 [75.0%]). ESH-ECs reported that 28% (median, interquartile range: 15-50%) had preexisting CKD, with 10% of them (5-30%) previously referred to a nephrologist, while 30% (15-40%) had resistant hypertension. The reported rate of previous recent (<6 months) estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) testing were 80% (50-95%) and 30% (15-50%), respectively. The reported use of renin-angiotensin system blockers was 80% (70-90%). When a nephrologist was part of the ESH-EC teams the reported rates SGLT2 inhibitors (27.5% [20-40%] vs. 15% [10-25], P = 0.003), GLP1-RA (10% [10-20%] vs. 5% [5-10%], P = 0.003) and mineralocorticoid receptor antagonists (20% [10-30%] vs. 15% [10-20%], P = 0.05) use were greater as compared to ESH-ECs without nephrologist participation. The rate of reported resistant hypertension, recent eGFR and UACR results and management of CKD patients prior to referral varied widely across countries. CONCLUSIONS: Our estimation indicates deficits regarding CKD screening, use of nephroprotective drugs and referral to nephrologists before referral to ESH-ECs but results varied widely across countries. This information can be used to build specific programs to improve care in hypertensives with CKD.
2nd Department of Cardiology Medical School University of Athens ATTIKON Hospital Athens
2nd Prop Department of Internal Medicine Aristotle University Thessaloniki Greece
AP HP Unité d'hypertension artérielle service de médecine interne Hôpital Avicenne Bobigny France
APHP Service d'Hypertension Artérielle Hôpital Européen Georges Pompidou Paris France
Cardiovascular Risk and Hypertension Hospital Madrid Spain
Cardiovascular Risk Clinic Western General Hospital Edinburgh UK
Center of Preventive Cardiology Hospital N2 CJSC Yerevan Armenia
Centre of Cardiology North Estonia Medical Centre Tallinn University of Technology Tallinn Estonia
Clinica Medica University Milano Bicocca Milan Italy
Danderyd University Hospital Corp Department of Cardiology Stockholm Sweden
Department of Advanced Medical Sciences Federico 2 University of Naples Naples Italy
Department of Cardiology Abdali Hospital Amman Jordan
Department of Cardiology Istituto Auxologico Italiano IRCCS Milan Italy
Department of Cardiology LAIKO General Hospital Athens Greece
Department of Cardiology Medical University of Graz Graz Austria
Department of Cardiovascular Diseases Internal Medicine University Hospital Ghent Ghent Belgium
Department of Clinical and Experimental Sciences University of Brescia and ASST Spedali Civili Italy
Department of Clinical Sciences Lund University Skane University Hospital Malmö Sweden
Department of Heart Disease Haukeland University Hospital Bergen Norway
Department of Internal Medicine IV
Department of Internal Medicine Nephrology Heinrich Heine University Duesseldorf Duesseldorf Germany
Department of Medical Sciences University of Turin Turin Italy
Department of Medicine and Surgery University of Milano Bicocca Milan Italy
Department of Medicine Radboud University Medical Center Nijmegen The Netherlands
Department of Nephrology Cantonal Hospital Graubuenden Chur Switzerland
Division of Medicine Turku University Hospital Turku University Turku Finland
Emergency Clinical Hospital of Bucharest Bucharest Romania
ESH Excellent Center Hypertension LAIKO University Hospital Athens Greece
Faculty of Medicine Oporto Portugal
Hôpital Ed Herriot Department of Nephrology and Hypertension Lyon
Hospital Universitario de Badajoz Badajoz Spain
Hypertension Unit Department of Cardiology HELORA University Hospitals Mons Belgium
Hypertension Unit Department of Internal Medicine Hospital Clinic University of Barcelona Spain
Hypertension Unit Department of Internal Medicine University Hospital of Heraklion Heraklion
Hypertension Unit KAT General Hospital of Attica Attica Greece
Izmir Medicana International Hospital Division of Cardiology Konak Izmir Turkey
Medical Outpatient Department and Hypertension Clinic University Hospital Basel Basel Switzerland
Medical University Innsbruck Austria
Medical University of Warsaw Warsaw Poland
Peart Rose Clinic Hammersmith Hospital Imperial College Healthcare Trust London UK
Plava Medical Group Sarajevo Bosnia and Herzegovina
School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece
Service d'HTA et Therapeutique CHU Rangueil Toulouse University Toulouse
Service de cardiologie Hôpital de la Timone Marseille France
Service de Médecine Interne Hôpital Franco Britannique Levallois Perret France
Service de Néphrologie CIC CRB 1404 INSERM EnVi U1096 CHU Rouen Rouen France
Service de Néphrologie transplantation dialyse aphérèses CHU Bordeaux France
South Buda Center Hospital St Imre University Teaching Hospital Budapest Hungary
St George University Medical Center Achrafieh Beirut Lebanon
St Josefs Hospital Cloppenburg Germany
Università Politecnica delle Marche and IRCCS INRCA Ancona Italy
Universitair Ziekenhuis Brussel VUB Belgium
Université Paris Cité Paris France
University Hospital of North Norway Tromsø Norway
University of Palermo Palermo Italy
Vascular Risk Unit Internal Medicine Virgen de las Nieves University Hospital Granada Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019179
- 003
- CZ-PrNML
- 005
- 20241024111635.0
- 007
- ta
- 008
- 241015s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/HJH.0000000000003756 $2 doi
- 035 __
- $a (PubMed)38747416
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Halimi, Jean-Michel $u Service de Néphrologie-Hypertension, Dialyses, Transplantation rénale, Hôpital Bretonneau, CHU Tours, Tours, France
- 245 10
- $a Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire / $c JM. Halimi, P. Sarafidis, M. Azizi, G. Bilo, T. Burkard, M. Bursztyn, M. Camafort, N. Chapman, S. Cottone, T. de Backer, J. Deinum, P. Delmotte, M. Dorobantu, M. Doumas, R. Dusing, B. Duly-Bouhanick, JP. Fauvel, P. Fesler, Z. Gaciong, E. Gkaliagkousi, D. Gordin, G. Grassi, C. Grassos, D. Guerrot, J. Huart, R. Izzo, FJ. Águila, Z. Járai, T. Kahan, I. Kantola, E. Kociánová, FP. Limbourg, M. Lopez-Sublet, F. Mallamaci, A. Manolis, M. Marketou, G. Mayer, A. Mazza, IM. MacIntyre, JJ. Mourad, ML. Muiesan, E. Nasr, P. Nilsson, A. Oliveras, O. Ormezzano, V. Paixão-Dias, I. Papadakis, D. Papadopoulos, S. Perl, J. Polónia, R. Pontremoli, G. Pucci, NR. Robles, S. Rubin, LM. Ruilope, LC. Rump, S. Saeed, E. Sanidas, R. Sarzani, R. Schmieder, F. Silhol, S. Sokolovic, M. Solbu, M. Soucek, G. Stergiou, I. Sudano, R. Tabbalat, I. Tengiz, H. Triantafyllidi, K. Tsioufis, J. Václavík, M. van der Giet, P. Van der Niepen, F. Veglio, RM. Venzin, M. Viigimaa, T. Weber, J. Widimsky, G. Wuerzner, P. Zelveian, P. Zebekakis, S. Lueders, A. Persu, R. Kreutz, L. Vogt, European Society of Hypertension Working Group on Hypertension, the Kidney
- 520 9_
- $a OBJECTIVE: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. METHODS: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (ESH-ECs) at first referral visit. The questionnaire contained 64 questions with which ESH-ECs representatives were asked to estimate preexisting CKD management quality. RESULTS: Overall, 88 ESH-ECs from 27 countries participated (fully completed surveys: 66/88 [75.0%]). ESH-ECs reported that 28% (median, interquartile range: 15-50%) had preexisting CKD, with 10% of them (5-30%) previously referred to a nephrologist, while 30% (15-40%) had resistant hypertension. The reported rate of previous recent (<6 months) estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) testing were 80% (50-95%) and 30% (15-50%), respectively. The reported use of renin-angiotensin system blockers was 80% (70-90%). When a nephrologist was part of the ESH-EC teams the reported rates SGLT2 inhibitors (27.5% [20-40%] vs. 15% [10-25], P = 0.003), GLP1-RA (10% [10-20%] vs. 5% [5-10%], P = 0.003) and mineralocorticoid receptor antagonists (20% [10-30%] vs. 15% [10-20%], P = 0.05) use were greater as compared to ESH-ECs without nephrologist participation. The rate of reported resistant hypertension, recent eGFR and UACR results and management of CKD patients prior to referral varied widely across countries. CONCLUSIONS: Our estimation indicates deficits regarding CKD screening, use of nephroprotective drugs and referral to nephrologists before referral to ESH-ECs but results varied widely across countries. This information can be used to build specific programs to improve care in hypertensives with CKD.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chronická renální insuficience $x komplikace $x patofyziologie $7 D051436
- 650 12
- $a hypertenze $x farmakoterapie $x komplikace $7 D006973
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a pilotní projekty $7 D010865
- 650 _2
- $a konziliární vyšetření a konzultace $7 D012017
- 650 _2
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a plošný screening $x metody $7 D008403
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sarafidis, Pantelis $u School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a Azizi, Michel $u Université Paris Cité, Paris, France; APHP, Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, Paris, France
- 700 1_
- $a Bilo, Grzegorz $u Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
- 700 1_
- $a Burkard, Thilo $u Medical Outpatient Department and Hypertension Clinic, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Bursztyn, Michael $u Hypertension Clinic, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, and Faculty of Medicine, Hadassah-Hebrew University, School of Medicine, Jerusalem, Israel
- 700 1_
- $a Camafort, Miguel $u Hypertension Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Spain
- 700 1_
- $a Chapman, Neil $u Peart-Rose Clinic, Hammersmith Hospital, Imperial College Healthcare Trust, London, UK
- 700 1_
- $a Cottone, Santina $u PROMISE Department, Nephrology and Dialysis Unit with Hypertension ESH Excellence Centre, University Hospital P. Giaccone; University of Palermo, Palermo, Italy
- 700 1_
- $a de Backer, Tine $u Department of Cardiovascular Diseases, Internal Medicine, University Hospital Ghent, Ghent, Belgium
- 700 1_
- $a Deinum, Jaap $u Department of Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
- 700 1_
- $a Delmotte, Philippe $u Hypertension Unit (European Society of Hypertension Excellence Centre), Department of Cardiology, HELORA University Hospitals, Mons, Belgium
- 700 1_
- $a Dorobantu, Maria $u Emergency Clinical Hospital of Bucharest, Bucharest, Romania
- 700 1_
- $a Doumas, Michalis $u 2nd Prop. Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a Dusing, Rainer $u Hypertoniezentrum Bonn, Schwerpunktpraxis Kardiologie, Angiologie, Prävention, Rehabilitation, Bonn, Germany
- 700 1_
- $a Duly-Bouhanick, Béatrice $u Service d'HTA et Therapeutique CHU Rangueil, Toulouse University, Toulouse
- 700 1_
- $a Fauvel, Jean-Pierre $u Hôpital Ed Herriot Department of Nephrology and Hypertension, Lyon
- 700 1_
- $a Fesler, Pierre $u Department of Internal Medicine, Montpellier University Hospital, Montpellier, France and PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier, France
- 700 1_
- $a Gaciong, Zbigniew $u Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Gkaliagkousi, Eugenia $u 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Greece
- 700 1_
- $a Gordin, Daniel $u Department of Nephrology, Helsinki University Hospital and University of Helsinki, Biomedicum 2 Helsinki, Helsinki, Finland
- 700 1_
- $a Grassi, Guido $u Clinica Medica, University Milano Bicocca, Milan Italy
- 700 1_
- $a Grassos, Charalampos $u Hypertension Unit, KAT General Hospital of Attica, Attica, Greece
- 700 1_
- $a Guerrot, Dominique $u Service de Néphrologie, CIC-CRB 1404, INSERM EnVi U1096, CHU Rouen, Rouen, France
- 700 1_
- $a Huart, Justine $u Division of Nephrology, University of Liège Hospital (ULg CHU), University of Liège, and Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, Belgium
- 700 1_
- $a Izzo, Raffaele $u Department of Advanced Medical Sciences, Federico II University of Naples, Naples, Italy
- 700 1_
- $a Águila, Fernando Jaén $u Vascular Risk Unit, Internal Medicine, Virgen de las Nieves University Hospital, Granada, Spain
- 700 1_
- $a Járai, Zoltán $u South-Buda Center Hospital, St. Imre University Teaching Hospital, Budapest, Hungary
- 700 1_
- $a Kahan, Thomas $u Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Stockholm, Sweden; and Danderyd University Hospital Corp, Department of Cardiology, Stockholm, Sweden
- 700 1_
- $a Kantola, Ilkka $u Division of Medicine Turku University Hospital, Turku University, Turku, Finland
- 700 1_
- $a Kociánová, Eva $u First Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Limbourg, Florian P $u Hypertension Center, Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
- 700 1_
- $a Lopez-Sublet, Marilucy $u AP-HP, Unité d'hypertension artérielle, service de médecine interne, Hôpital Avicenne, Bobigny, France
- 700 1_
- $a Mallamaci, Francesca $u Grande Ospedale Metropolitano, UOC di Nefrologia abilitata al trapianto renale, CNR Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Arteriosa, Reggio Calabria, Italy
- 700 1_
- $a Manolis, Athanasios $u Metropolitan Hospital, Piraeus
- 700 1_
- $a Marketou, Maria $u Hypertension Outpatient Clinic, Cardiology Department, Heraklion University General Hospital, Heraklion, Crete, Greece
- 700 1_
- $a Mayer, Gert $u Department of Internal Medicine IV (Nephrology and Hypertension); Medical University Innsbruck, Austria
- 700 1_
- $a Mazza, Alberto $u UOC Medicina Interna, Centro Ipertensione di Eccellenza Europea ESH, Azienda ULSS 5 Polesana - Ospedale di Adria (RO), Italy
- 700 1_
- $a MacIntyre, Iain M $u Cardiovascular Risk Clinic, Western General Hospital, Edinburgh, UK
- 700 1_
- $a Mourad, Jean-Jacques $u Service de Médecine Interne, Hôpital Franco-Britannique, Levallois-Perret, France
- 700 1_
- $a Muiesan, Maria Lorenza $u Department of Clinical and Experimental Sciences, University of Brescia and ASST Spedali Civili, Italy
- 700 1_
- $a Nasr, Edgar $u St George University Medical Center, Achrafieh-Beirut, Lebanon
- 700 1_
- $a Nilsson, Peter $u Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden
- 700 1_
- $a Oliveras, Anna $u Hypertension and Vascular Risk Unit, Department of Nephrology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Universitat Pompeu Fabra, Barcelona, Catalonia, Spain
- 700 1_
- $a Ormezzano, Olivier $u UF Hypertension et Athérothrombose, Centre Européen d'Excellence en Hypertension Artérielle, Service de Cardiologie, Pôle Thorax et Vaisseaux, CHU Michallon, Grenoble, France
- 700 1_
- $a Paixão-Dias, Vitor $u Hospital Centre of Vila Nova de Gaia/Espinho, Internal Medicine Department, Hypertension and Cardiometabolic Risk Unit, ESH Excellence Centre, Vila Nova de Gaia, Portugal
- 700 1_
- $a Papadakis, Ioannis $u Hypertension Unit, Department of Internal Medicine, University Hospital of Heraklion, Heraklion
- 700 1_
- $a Papadopoulos, Dimitris $u ESH Excellent Center Hypertension, LAIKO University Hospital, Athens, Greece
- 700 1_
- $a Perl, Sabine $u Department of Cardiology, Medical University of Graz, Graz, Austria
- 700 1_
- $a Polónia, Jorge $u Faculty of Medicine Oporto, Portugal
- 700 1_
- $a Pontremoli, Roberto $u Clinica di Medicina Interna 2, Università degli Studi e IRCCS Ospedale Policlinico San Martino di Genova
- 700 1_
- $a Pucci, Giacomo $u Department of Medicine and Surgery - University of Perugia Unit of Internal Medicine - Santa Maria Terni Hospital, Terni, Italy
- 700 1_
- $a Robles, Nicolás Roberto $u Hospital Universitario de Badajoz, Badajoz, Spain
- 700 1_
- $a Rubin, Sébastien $u Service de Néphrologie -transplantation-dialyse-aphérèses, CHU Bordeaux, France
- 700 1_
- $a Ruilope, Luis Miguel $u Cardiovascular Risk and Hypertension Hospital, Madrid, Spain
- 700 1_
- $a Rump, Lars Christian $u Department of Internal Medicine/ Nephrology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
- 700 1_
- $a Saeed, Sahrai $u Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
- 700 1_
- $a Sanidas, Elias $u Department of Cardiology, LAIKO General Hospital, Athens, Greece
- 700 1_
- $a Sarzani, Riccardo $u Università Politecnica delle Marche and IRCCS-INRCA, Ancona, Italy
- 700 1_
- $a Schmieder, Roland $u Department of Nephrology and Hypertension University Hospital Erlangen, Friedrich Alexander University Erlangen/Nürnberg, Erlangen, Germany
- 700 1_
- $a Silhol, François $u Service de cardiologie, Hôpital de la Timone, Marseille, France
- 700 1_
- $a Sokolovic, Sekib $u Plava Medical Group, Sarajevo, Bosnia and Herzegovina
- 700 1_
- $a Solbu, Marit $u University Hospital of North Norway, Tromsø, Norway
- 700 1_
- $a Soucek, Miroslav $u 2nd Deparment od Internal Medicine of St. Anne's University Hospital Brno and Fakulty of Medicine Masaryk University, Brno, Czechia
- 700 1_
- $a Stergiou, George $u Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
- 700 1_
- $a Sudano, Isabella $u University Hospital Zurich University Heart Center, Cardiology and University of Zurich, Zurich, Switzerland
- 700 1_
- $a Tabbalat, Ramzi $u Department of Cardiology, Abdali Hospital, Amman, Jordan
- 700 1_
- $a Tengiz, Istemihan $u Izmir Medicana International Hospital, Division of Cardiology, Konak/Izmir, Turkey
- 700 1_
- $a Triantafyllidi, Helen $u 2nd Department of Cardiology, Medical School, University of Athens, ATTIKON Hospital, Athens
- 700 1_
- $a Tsioufis, Konstontinos $u 1st Department of Cardiology, National and Kapodistrian University of Athens, Hippocratio Hospital, Greece
- 700 1_
- $a Václavík, Jan $u Department of Internal Medicine and Cardiology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic
- 700 1_
- $a van der Giet, Markus $u Charité - Universitätsmedizin Berlin, Medinische Klinik für Nephrologie und internistische Intensivtherapie, Berlin, Germany
- 700 1_
- $a Van der Niepen, Patricia $u Universitair Ziekenhuis Brussel, VUB, Belgium
- 700 1_
- $a Veglio, Franco $u Department of Medical Sciences, University of Turin, Turin, Italy
- 700 1_
- $a Venzin, Reto M $u Department of Nephrology, Cantonal Hospital Graubuenden, Chur, Switzerland
- 700 1_
- $a Viigimaa, Margus $u Centre of Cardiology, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia
- 700 1_
- $a Weber, Thomas $u Klinikum Wels-Grieskirchen
- 700 1_
- $a Widimsky, Jiri $u Centre for Hypertension, IIIrd Internal Department, General Faculty Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Wuerzner, Grégoire $u Service de néphrologie et d'hypertension, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Zelveian, Parounak $u Center of Preventive Cardiology, Hospital N2 CJSC, Yerevan, Armenia
- 700 1_
- $a Zebekakis, Pantelis $u Hypertension Unit of the First Department of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki
- 700 1_
- $a Lueders, Stephan $u St. Josefs Hospital, Cloppenburg Germany
- 700 1_
- $a Persu, Alexandre $u Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
- 700 1_
- $a Kreutz, Reinhold $u Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany
- 700 1_
- $a Vogt, Liffert $u Department of Internal Medicine, Section of Nephrology, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands
- 710 2_
- $a European Society of Hypertension Working Group on Hypertension, the Kidney
- 773 0_
- $w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 42, č. 9 (2024), s. 1544-1554
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38747416 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111629 $b ABA008
- 999 __
- $a ok $b bmc $g 2201798 $s 1231152
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 42 $c 9 $d 1544-1554 $e 20240513 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
- LZP __
- $a Pubmed-20241015
